Akihisa Okumura Selected Research

Electrolytes

10/2015	Efficacy and safety of fosphenytoin for benign convulsions with mild gastroenteritis.
12/2002	Clinical features of benign convulsions with mild gastroenteritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihisa Okumura Research Topics

Disease

33	Seizures (Absence Seizure) 01/2021 - 01/2002
20	Brain Diseases (Brain Disorder) 01/2024 - 01/2002
12	Epilepsy (Aura) 10/2023 - 04/2004
9	Fever (Fevers) 01/2023 - 02/2006
7	Infections 01/2023 - 08/2007
6	Gastroenteritis 08/2020 - 12/2002
6	Febrile Seizures (Febrile Seizure) 01/2019 - 08/2007
6	Human Influenza (Influenza) 01/2017 - 06/2006
5	Hypersensitivity (Allergy) 06/2022 - 05/2007
5	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022 - 01/2019
5	Spasm (Spasms) 01/2021 - 02/2002
5	Partial Epilepsies (Epilepsy, Partial) 04/2016 - 10/2006
4	Dyskinesias (Dyskinesia) 01/2021 - 03/2012
4	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 02/2012
4	Periventricular Leukomalacia (Neonatal Cerebral Leukomalacia) 02/2008 - 01/2002
3	Status Epilepticus (Complex Partial Status Epilepticus) 12/2022 - 01/2014
3	Kernicterus 01/2021 - 09/2015
3	Leukocytosis (Pleocytosis) 10/2018 - 01/2014
3	Infantile Spasms (West Syndrome) 05/2017 - 08/2005
3	Delirium 06/2013 - 02/2006
3	Brain Injuries (Brain Injury) 09/2012 - 08/2007
3	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 12/2010 - 11/2006
2	COVID-19 02/2023 - 01/2022
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 02/2023 - 01/2021
2	Disease Progression 01/2022 - 06/2013
2	Leukemia 01/2022 - 04/2016
2	Familial paroxysmal dystonia 09/2020 - 11/2007
2	Birth Weight (Birth Weights) 02/2020 - 09/2012
2	Dehydration (Water Stress) 10/2015 - 12/2002
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2013 - 11/2006
2	Ischemia 01/2013 - 08/2007
2	Hypoxia (Hypoxemia) 01/2013 - 08/2007
2	Unconsciousness (Loss of Consciousness) 09/2012 - 02/2009
2	Drug Hypersensitivity (Drug Allergy) 11/2007 - 06/2007
1	Food Hypersensitivity (Food Allergy) 01/2023
1	Obstructive Jaundice (Cholestatic Jaundice) 01/2023
1	Biliary Atresia 01/2023
1	Vitamin K Deficiency Bleeding 01/2023
1	Neonatal Jaundice 01/2023
1	Jaundice (Icterus) 01/2023
1	Hippocampal Sclerosis 12/2022
1	Erythema 06/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2022

Drug/Important Bio-Agent (IBA)

17	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 01/2002
9	Phenobarbital (Luminal)FDA Link 09/2016 - 10/2006
8	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 01/2002
7	CytokinesIBA 11/2014 - 11/2006
6	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2018 - 08/2005
6	Phenytoin (Dilantin)FDA LinkGeneric 11/2007 - 01/2002
5	BilirubinIBA 01/2023 - 09/2015
5	SteroidsIBA 01/2022 - 09/2006
5	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022 - 01/2011
5	Methylprednisolone FDA LinkGeneric 07/2021 - 02/2014
4	Lacosamide FDA Link 12/2021 - 08/2020
4	Oxygen (Dioxygen)IBA 07/2021 - 12/2010
4	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 05/2007
4	AntibodiesIBA 01/2021 - 03/2015
4	Proteins (Proteins, Gene)FDA Link 03/2015 - 10/2010
4	Diazepam (Valium)FDA LinkGeneric 01/2011 - 05/2004
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2011
3	Levetiracetam (Keppra)FDA LinkGeneric 11/2021 - 07/2011
3	Lamotrigine (Lamictal)FDA LinkGeneric 09/2016 - 08/2013
3	tau Proteins (tau Protein)IBA 01/2014 - 06/2010
3	Lidocaine (Xylocaine)FDA LinkGeneric 08/2013 - 12/2004
2	perampanelIBA 10/2023 - 01/2021
2	nusinersenIBA 02/2023 - 01/2021
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2002
2	Sodium Channel BlockersIBA 12/2021 - 11/2021
2	EstersIBA 07/2021 - 06/2007
2	antineoplaston A10 (A 10)IBA 01/2021 - 01/2019
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 03/2018
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2014
2	Oseltamivir (Tamiflu)FDA Link 01/2017 - 06/2006
2	fosphenytoin (Cerebyx)FDA LinkGeneric 10/2015 - 04/2015
2	ElectrolytesIBA 10/2015 - 12/2002
2	VaccinesIBA 02/2015 - 11/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2014 - 08/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2014 - 08/2007
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2014 - 06/2013
2	Midazolam (Versed)FDA LinkGeneric 08/2013 - 09/2008
2	Glucose (Dextrose)FDA LinkGeneric 09/2012 - 05/2012
2	Docosahexaenoic AcidsIBA 12/2010 - 12/2009
2	AntipyreticsIBA 05/2009 - 02/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2009 - 05/2003
2	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 11/2007 - 06/2007
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2024
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2024
1	Immunoglobulin E (IgE)IBA 01/2023
1	Vitamin K FDA Link 01/2023
1	AntigensIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 12/2022
1	Methotrexate (Mexate)FDA LinkGeneric 06/2022

Therapy/Procedure

21	Therapeutics 06/2022 - 02/2002
3	Aftercare (After-Treatment) 01/2022 - 10/2006
2	Enteral Nutrition (Feeding, Tube) 02/2020 - 09/2010
2	Artificial Respiration (Mechanical Ventilation) 09/2012 - 10/2002
2	Electrodes (Electrode) 11/2009 - 01/2002
1	Hepatic Portoenterostomy 01/2023
1	Lasers (Laser) 01/2023
1	Drug Tapering 06/2022